From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

QLD Hot Topic Webinar – Hepatitis B and Liver Cancer

Course duration
1 hour 16 minutes
Course Type
On Demand
Course duration
1 hour 16 minutes
Course Type
On Demand

This hot topic webinar focuses on the impact of unmanaged chronic hepatitis B on primary liver cancer. This is one of the biggest known risk factors and this webinar will assist with understanding the statistics and when to support surveillance and referral.

Learn from experts in liver cancer treatment and join us for presentations and discussion on liver cancer data with Hepatitis Queensland and Cancer Council Queensland.

Learning outcomes:

  • Describe the epidemiology of hepatitis B and its link to hepatocellular carcinoma
  • Recognise indications for liver cancer surveillance and outline surveillance process enabling discussions around prevention
  • Recognise early signs of malignancy and understand referral pathways

HBV s100 Prescribers will receive 1 HBV Prescriber Point at the completion of the recording.

Funders:

This activity is funded by Queensland Health. 

For more information:

Please contact ASHM Education at [email protected] or call 0431 320 429.